Article Information
History
- December 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Arola Anne1,2,*,
- Levänen Tuuli1,
- M. Laakso Hanna1,2,
- Pitkänen Johanna3,
- Koikkalainen Juha4,5,
- Lötjönen Jyrki4,6,
- Korvenoja Antti7,
- Erkinjuntti Timo3,
- Melkas Susanna3 and
- Jokinen Hanna1,2
- 1HUS Neurocenter, Division of Neuropsychology, Helsinki University Hospital and University of Helsinki
- 2Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki
- 3Department of Neurology, Helsinki University Hospital and University of Helsinki
- 4Combinostics Ltd, Tampere
- 5Faculty of Health Sciences, University of Eastern Finland, Kuopio
- 6Department of Neuroscience and Biomedical Engineering, School of Science, Aalto University, Espoo, Finland
- 7HUS Diagnostic Center, Radiology, Helsinki University Hospital and University of Helsinki
- ↵*Correspondence: Anne Arola, MSc, Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Finland, anne.arola{at}helsinki.fi
Posted December 21, 2021.
Neuropsychiatric symptoms are associated with exacerbated cognitive impairment in covert cerebral small vessel disease
